GTC Biotherapeutics (fka GTCB)

[waynebio]

Yes look at the market cap!! The current market cap value for GTCB is $20mm lower than the value of the tax write off on all the net losses incurred to date. Unless either GTCB goes bankrupt with $80+mm of debt or GTCB starts accumulating hundreds of millions of net income, there will be tax write off value to GTCB. I think this alone is proof that the stock price is too low. This is further self reinforcing pressure on the stock price since anticipated dilution to raise cash at too low of a price will require more shares to need to be issued than otherwise would have.

Does anyone know if most small biotechs have poison pills in place?